Supernus, Inc.: shareholders and insiders

SUPNNASDAQHealthcare · Pharmaceutical Preparations

Price

$28.96

November 18, 2026Market cap $3.4B

What Ploutos Investor adds for Supernus

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 5 fiscal years, from 2021
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Jan 5, 2026 to Nov 4, 2026, from their own Form 4 filings.

15 Form 4s

Insider trades start on January 7, 2026

Until lately Supernus was a foreign company listed in the US. Officers of foreign companies do not report their purchases and sales, so there are none before. They are not missing on our side: they were never filed.

  1. Until 2024Foreign company (annual report on 20-F)
  2. March 2025Becomes a US filer (annual report on 10-K)
  3. January 7, 2026The first insider trade report (Form 4)

Bought on the market

$311.6K

7 people

Sold on the market

$2.8M

2 people

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan100%
  • The rest0%
  • Nov 2, 2026Frank MottolaSVP, Chief Tech. Ops. Officer
    Kind
  • Nov 2, 2026Timothy C DecSVP, Chief Financial Officer
    Kind
  • Nov 2, 2026Carrolee BarlowDirector
    Kind
  • Nov 2, 2026Padmanabh P. BhattSVP of IP, CSO
    Kind
  • Nov 2, 2026Georges GemayelDirector
    Kind
  • Nov 2, 2026Jack A. KhattarChief Executive Officer
    Kind
  • Nov 2, 2026Jack A. KhattarChief Executive Officer
    Kind
  • Nov 2, 2026Jonathan RubinSVP, Chief Medical Officer
    Kind
  • Aug 27, 2026Woodrow D AndersonChief Accounting Officer
    Kind
  • Aug 5, 2026Woodrow D AndersonChief Accounting Officer
    Kind
  • Jul 10, 2026Christian HeidbrederChief Scientific Officer
    Kind10b5-1
  • Jun 22, 2026Joseph CiaffoniChief Executive Officer
    Kind
  • Jun 22, 2026Joseph CiaffoniChief Executive Officer
    Kind
  • Jun 11, 2026Christian HeidbrederChief Scientific Officer
    Kind10b5-1
  • Jun 8, 2026Ryan PreblickChief Financial Officer
    Kind10b5-1
  • Mar 13, 2026Barbara Ryan
    Kind
  • Mar 9, 2026Barbara Ryan
    Kind
  • Mar 6, 2026Stuart A Kingsley
    Kind
  • Jan 5, 2026Daniel A Ninivaggi
    Kind10b5-1
  • Jan 5, 2026Mark Stejbach
    Kind10b5-1
  • Jan 5, 2026David E. Wheadon
    Kind10b5-1
  • Jan 5, 2026Barbara Ryan
    Kind10b5-1
  • Jan 5, 2026Keith Humphreys
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 10, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

4 Holders over 5%Sep 30, 2026 Latest filing
  • BlackRock, Inc.
    Share of class14.3%
  • Vanguard Portfolio Management
    Share of class6.55%
  • Millennium Management LLCwith 2 more persons
    Share of class5.40%
  • Vanguard Capital Management
    Share of class5.35%
Fell to 5% or less (7)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Oaktree Value Opportunities Fund, L.P.13D0.76%Aug 13, 202613D/A
  • Madison Avenue International LP3.50%May 15, 202613G/A
  • Fuller & Thaler Asset Management, Inc.3.72%May 13, 202613G/A
  • The Goldman Sachs Group2.90%Feb 12, 202613G/A
  • Two Seas Capital LP13D4.98%Dec 23, 202513D/A
  • Deerfield Mgmt, L.P.3.70%Nov 13, 202513G/A
  • Morgan Stanley3.70%May 6, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Renaissance Technologies
    In the quarter-23%
  • Millennium Mgmt (Englander)
    In the quarter-49%
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter-40%
  • D.E. Shaw
    In the quarter-27%
  • AQR Capital
    In the quarter-71%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short sales in daily trading

How much of the shares that changed hands were short sales, in the off-exchange trades brokers report each day.

61.8% the last 13 sessions+1.1 pts vs the 14 before

In the last 13 sessions, 61.8% of the shares in the reported trades were short sales, against 60.7% in the 14 before.

Last 13 sessionsOct 30, 2026 – Nov 18, 2026
61.8%
The 14 beforeOct 12, 2026 – Oct 29, 2026
60.7%
Change
+1.1 pts
Short sales a dayon average, of 1.55M shares
959.3K
More than atof 3,656 US-listed companies, same days
86%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 60.4%
  • Oct 13, 2026: Short sales 44.6%
  • Oct 14, 2026: Short sales 64.1%
  • Oct 15, 2026: Short sales 69.7%
  • Oct 16, 2026: Short sales 50.6%
  • Oct 19, 2026: Short sales 61.2%
  • Oct 20, 2026: Short sales 52.7%
  • Oct 21, 2026: Short sales 73.9%
  • Oct 22, 2026: Short sales 56.2%
  • Oct 23, 2026: Short sales 49.5%
  • Oct 26, 2026: Short sales 56.2%
  • Oct 27, 2026: Short sales 69.7%
  • Oct 28, 2026: Short sales 71.5%
  • Oct 29, 2026: Short sales 73.3%
  • Oct 30, 2026: Short sales 82.4%
  • Nov 3, 2026: Short sales 52%
  • Nov 4, 2026: Short sales 57.2%
  • Nov 5, 2026: Short sales 53.8%
  • Nov 6, 2026: Short sales 51.6%
  • Nov 9, 2026: Short sales 58.7%
  • Nov 10, 2026: Short sales 63.1%
  • Nov 11, 2026: Short sales 64.2%
  • Nov 12, 2026: Short sales 79.8%
  • Nov 13, 2026: Short sales 74%
  • Nov 16, 2026: Short sales 75.2%
  • Nov 17, 2026: Short sales 67.3%
  • Nov 18, 2026: Short sales 53%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half. Shares held short, which are published twice a month, are not included here.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

4.91M Insiders' shares3.93% Of the company
  • Jack A. KhattarChief Executive Officer
    Directly3.41M
  • Joseph CiaffoniChief Executive Officer
    Directly790.3K
  • Ryan PreblickChief Financial Officer
    Directly284.8K
  • Christian HeidbrederChief Scientific Officer
    Directly209.3K
  • Georges GemayelDirector
    Directly42.0K
  • Carrolee BarlowDirector
    Directly41.7K
  • Frank MottolaSVP, Chief Tech. Ops. Officer
    Directly30.1K
  • Padmanabh P. BhattSVP of IP, CSO
    Directly28.7K
  • Woodrow D AndersonChief Accounting Officer
    Directly27.6K
  • Jonathan RubinSVP, Chief Medical Officer
    Directly21.5K
  • Timothy C DecSVP, Chief Financial Officer
    Directly14.1K
  • Barbara RyanDirector
    Directly5,724
  • Stuart A KingsleyDirector
    Directly5,582

A lower bound: it counts only the 13 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

334 Managers, Q2 2026$2.8B Value of their positions
  • Q3 2025: Managers 312
  • Q4 2025: Managers 333
  • Q1 2026: Managers 330
  • Q2 2026: Managers 334

Institutional investors by quarter

The fund managers holding SUPN, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 334 managers held 60.33M shares, worth $2.8B. During the quarter 47 opened a position, 43 closed one, 115 added and 111 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+6.3%
  • Millennium Mgmt (Englander)
    In the quarter+16%
  • Vanguard Portfolio Management
    In the quarter+2.1%
  • Armistice Capital
    In the quarter+40%
  • Vanguard Capital Management
    In the quarter+2.0%
  • State Street
    In the quarter+7.5%
  • Nomura Asset Management International
    In the quarter+17%
  • Dimensional Fund Advisors
    In the quarter-9.9%
  • Geode Capital Management
    In the quarter-3.3%
  • Stephens Investment Management Group
    In the quarter+10.0%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Supernus's filings show?

Who buys and sells is one part of Supernus's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SUPN's shareholders

Didn't find what you were looking for?

Ask us
Have SUPN's insiders bought or sold?

From Jun 10, 2026 to Nov 4, 2026 Supernus's insiders bought $108.0K and sold $2.8M of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold SUPN?

6 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $85M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.